Related Experiment Video
Updated: Jul 16, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis: diagnosis, management, and cardiovascular implications
Robert T Eberhardt1, Mandeep Dhadly
1Vascular Medicine Program, Division of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. robert.eberhardt@bmc.org
Cardiology in Review
|February 17, 2007
Summary
Giant cell arteritis is a common vasculitis affecting arteries, potentially causing vision loss and other serious vascular issues. Early corticosteroid treatment can prevent severe outcomes like blindness.
Area of Science:
- Rheumatology
- Vascular Medicine
- Systemic Vasculitis
Background:
- Giant cell arteritis (GCA) is a prevalent systemic vasculitis.
- It commonly affects extracranial branches of the carotid artery.
- GCA poses a significant risk for irreversible visual loss.
Purpose of the Study:
- To review the pathophysiology of giant cell arteritis.
- To outline the clinical manifestations of giant cell arteritis.
- To provide a rationale for the diagnosis and therapy of GCA.
Main Methods:
- Literature review on giant cell arteritis.
- Synthesis of current understanding of GCA pathophysiology.
- Analysis of clinical presentations and diagnostic criteria.
Main Results:
- GCA can lead to stroke, aortic aneurysm/dissection, and rupture.
- Cardiac manifestations include coronary artery disease and left ventricular dysfunction.
- Early corticosteroid use is crucial for preventing visual loss.
Conclusions:
- Physicians must maintain vigilance for giant cell arteritis.
- Prompt diagnosis and treatment are essential.
- Corticosteroids are effective in preventing devastating outcomes.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...